Leafix Medical

Company Overview

Snapshot

Founded in January 2025 by Ron Szekely, Leafix Medical operates with 1–10 employees. The company has raised $6.5M across two funding rounds from one investor. In July 2025, Leafix Medical secured a Seed funding round.

Business overview

Leafix Medical is a Health Tech & Life Sciences company focused on developing a transcatheter solution for functional mitral valve regurgitation. The company's core technology involves an implant and delivery system designed to augment the anterior leaflet, thereby enlarging its area and creating coaptation of the leaflets. Leafix Medical operates within the Medical Devices and Medical Treatment & Therapeutics sectors, serving the healthcare industry, particularly providers.

Strategic signal

In July 2025, Leafix Medical secured a Seed funding round, indicating strong early investor confidence in its novel transcatheter solution for functional mitral regurgitation. This investment, led by Pitango HealthTech, validates the company's innovative approach to addressing a significant cardiovascular health challenge and signals potential for rapid development and market entry in the medical device sector.

Company Intelligence Q&A

When was Leafix Medical founded?

Leafix Medical was founded in January 2025 by Ron Szekely.

What is Leafix Medical's primary focus?

Leafix Medical focuses on developing a transcatheter solution for functional mitral valve regurgitation, utilizing an implant and delivery system to augment the anterior leaflet.

Which investor led Leafix Medical's Seed funding round?

In July 2025, Pitango HealthTech led Leafix Medical's Seed funding round, which was part of a total of $6.5M raised across two funding rounds.

What type of funding did Leafix Medical receive in January 2025?

In January 2025, Leafix Medical secured a grant from the Israel Innovation Authority.

What is the total capital raised by Leafix Medical?

Leafix Medical has raised a total of $6.5M across two funding rounds.